Keep up to date with Insol Europe news on our LinkedIn profile page...

 

​Kanabo calls in administrators marking an end to the LSE Cannabish Rush

Kanabo Group, once a flagship medical-cannabis firm on the London Stock Exchange, has entered administration as of 28 November 2025, marking a dramatic collapse for what was once considered a leader of…

​General Prosecutor's Office: Euroins bankruptcy, caused by fraudulent management, embezzlement and money laundering

The Romanian General Prosecutor's Office is conducting a major investigation into the bankruptcy of insurance company Euroins, which has been severely affecting the compulsory auto insurance market in…

German auto supplier near Nuremberg files for insolvency, putting over 1,000 jobs at risk

The German automotive plastics supplier, Diepersdorf Plastic Manufacturing, has filed for insolvency at the Nuremberg District Court, placing over 1,000 jobs at risk across its three German sites. The…

Stockholm based Maximum Entertainment AB has entered a restructuring term sheet with its main lender

Stockholm based Maximum Entertainment AB has entered a restructuring term sheet with its main lender, Olivine Holdings, LLC, to overhaul its capital structure and avoid full insolvency. The company, headquartered…

  • DownloadSorry you are not allowed to access this file.

News

​Kanabo calls in administrators marking an end to the LSE Cannabish Rush

Kanabo Group, once a flagship medical-cannabis firm on the London Stock Exchange, has entered administration as of 28 November 2025, marking a dramatic collapse for what was once considered a leader of Europe’s cannabis boom.

Joint administrators from RSM UK Restructuring Advisory LLP have been appointed to explore options around restructuring, selling the business or winding-down operations.

Kanabo’s demise completes the downfall of the original wave of four cannabis-listed firms on the LSE from 2021, all of which have now collapsed.
Despite early hype and a pivot from medical devices to digital health platforms, persistent regulatory burden, lack of institutional funding, and chronic financial losses undermined its long-term viability.

Initial hype and a strategic pivot from medical devices to digital health platforms couldn't overcome the core challenges, mainly due to the regulatory burden, a lack of funding, and sustained financial losses which ultimately compromised the company's long-term viability.

More on this at Business of Cannabis
  BENCHMARKS  
Loading Time: Base Classes  0.0009
Controller Execution Time ( News / News Details )  0.0061
Total Execution Time  0.0072
  GET DATA  
No GET data exists
  MEMORY USAGE  
797,528 bytes
  POST DATA  
No POST data exists
  URI STRING  
news/details/%E2%80%8Bkanabo-calls-in-administrators-marking-an-end-to-the-lse-cannabish-rush
  CLASS/METHOD  
news/news_details
  DATABASE:  insoleur_main   QUERIES: 45  (Show)
  HTTP HEADERS  (Show)
  SESSION DATA  (Show)
  CONFIG VARIABLES  (Show)